To test this hypothesis, we first determined the HIF-2α mRNA levels in bladder cancer cells and found little changes in the levels of HIF-2α regardless of the amount of RON expressed by cancer cells (Fig. 4B). The gene discussed is EPAS1; the disease is urinary bladder cancer.